The Patent Finder

Methods for Making and Using Endoxifen

Atossa Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application PCT/US2018/050272, filed Sep 10, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,572,334Methods for Making and Using Endoxifen
In force
 · High confidence
Atossa Therapeutics, Inc.In force
High confidence
US 11,680,036Methods for Making and Using Endoxifen
In force
 · High confidence
Atossa Therapeutics, Inc.In force
High confidence
US 12,071,391Methods for Making and Using Endoxifen
In force
 · Medium confidence
Atossa Therapeutics, Inc.In force
Medium confidence
US 12,275,684Methods for Making and Using Endoxifen
In force
 · Medium confidence
Atossa Therapeutics, Inc.In force
Medium confidence
US 12,281,056Methods for Making and Using Endoxifen
In force
 · High confidence
Atossa Therapeutics, Inc.In force
High confidence
US 12,479,790Methods for Making and Using Endoxifen
In force
 · High confidence
Atossa Therapeutics, Inc.In force
High confidence
US 11,261,151Methods for Making and Using Endoxifen
In force
 · High confidence
Atossa Therapeutics, Inc.In force
High confidence
Application 19/041,975Methods for Making and Using Endoxifen
Pending
Not granted
Atossa Therapeutics, Inc.PendingNot granted
Application 19/347,467Methods for Making and Using Endoxifen
Pending
Not granted
Atossa Therapeutics, Inc.PendingNot granted
Application 19/564,021Methods for Making and Using Endoxifen
Pending
Not granted
Atossa Therapeutics, Inc.PendingNot granted
4 more patents in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
Upgrade to Pro
7 of these are in force and held by Atossa Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited